HighTower Advisors’s Rockwell Medical RMTI Stock Holding History

HighTower Advisors’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,352	Closed	-$83.5K	–	3984
2026 Q1	$83.5K	Hold	9,352	–	–	﹤0.01%	3657
2025 Q4	$78K	Hold	9,352	–	–	﹤0.01%	3539
2025 Q3	$112K	Hold	9,352	–	–	﹤0.01%	3521
2025 Q2	$79.3K	Buy	9,352 +3,611	+63%	+$36.8K	﹤0.01%	3506
2025 Q1	$64.9K	Hold	5,741	–	–	﹤0.01%	3423
2024 Q4	$117K	Hold	5,741	–	–	﹤0.01%	3343
2024 Q3	$228K	Buy	5,741 +2,471	+76%	+$66.5K	﹤0.01%	3039
2024 Q2	$58K	Hold	3,270	–	–	﹤0.01%	3284
2024 Q1	$54K	Hold	3,270	–	–	﹤0.01%	3246
2023 Q4	$62K	Sell	3,270 -2	-0.1%	-$38	﹤0.01%	3268
2023 Q3	$68K	Buy	+3,272	New	+$99.4K	﹤0.01%	3183
2022 Q2	–	Sell	-318	Closed	-$16K	–	3490
2022 Q1	$16K	Buy	318 +3	+1%	+$127	﹤0.01%	3186
2021 Q4	$14K	Hold	315	–	–	﹤0.01%	3142
2021 Q3	$21K	Hold	315	–	–	﹤0.01%	2995
2021 Q2	$32K	Buy	+315	New	+$32.5K	﹤0.01%	2926

Other funds holding RMTI

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

WANY

Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HighTower Advisors's RMTI Position: Q2 2026 in Review

HighTower Advisors sold out of Rockwell Medical (RMTI) in Q2 2026, closing a stake of 9,352 shares — an estimated $83.5K sold.

HighTower Advisors first reported a position in RMTI in Q2 2021 and held it in 15 quarters. The position peaked at $228K in Q3 2024. 37 funds tracked by Wall St. Rank hold RMTI as of Q2 2026.

HighTower Advisors reported no remaining Rockwell Medical position as of Q2 2026 after selling out during the quarter.
HighTower Advisors sold 9,352 Rockwell Medical shares in Q2 2026, an estimated $83.5K.
HighTower Advisors first reported a position in Rockwell Medical in Q2 2021 and held it in 15 quarters.
HighTower Advisors's Rockwell Medical position peaked at $228K in Q3 2024.
37 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.